Investigational anti IL-13 asthma treatments: a 2023 update.
Sign Up to like & getrecommendations! Published in 2023 at "Expert opinion on investigational drugs"
DOI: 10.1080/13543784.2023.2215425
Abstract: INTRODUCTION IL-13 is a pleiotropic type 2 cytokine important in the pathogenesis of asthma and other eosinophilic disorders. AREAS COVERED Different attempts to directly neutralise IL-13 or block its receptors and the possible impact that… read more here.
Keywords: 2023 update; asthma treatments; asthma; anti asthma ... See more keywords